fenclonine has been researched along with Diseases, Metabolic in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Excerpt | Relevance | Reference |
---|---|---|
"Both groups of carcinoid patients had a comparable decrease in their insulinogenic index." | 1.25 | Glucose intolerance in the carcinoid syndrome. ( Bivens, CH; Feldman, JM; Lebovitz, HE; Plonk, JW, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feldman, JM | 1 |
Plonk, JW | 1 |
Bivens, CH | 1 |
Lebovitz, HE | 1 |
Delvalle, JA | 1 |
Dienel, G | 1 |
Greengard, O | 1 |
2 other studies available for fenclonine and Diseases, Metabolic
Article | Year |
---|---|
Glucose intolerance in the carcinoid syndrome.
Topics: Adult; Aged; Carcinoid Tumor; Cyproheptadine; Diabetes Mellitus; Female; Fenclonine; Glucose; Glucos | 1975 |
Comparison of alpha-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats.
Topics: Animals; Brain; Fenclonine; Liver; Metabolic Diseases; Methyltyrosines; Phenylalanine; Phenylalanine | 1978 |